These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27920755)

  • 1. Finding Potential Therapeutic Targets against
    Hossain MU; Khan MA; Hashem A; Islam MM; Morshed MN; Keya CA; Salimullah M
    Front Microbiol; 2016; 7():1817. PubMed ID: 27920755
    [No Abstract]   [Full Text] [Related]  

  • 2. Computational Identification of Essential Enzymes as Potential Drug Targets in
    Narad P; Himanshu ; Bansal H
    J Microbiol Biotechnol; 2021 Apr; 31(4):621-629. PubMed ID: 33323673
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of potential drug targets and inhibitor of the pathogenic bacteria
    Oany AR; Mia M; Pervin T; Hasan MN; Hirashima A
    In Silico Pharmacol; 2018; 6(1):11. PubMed ID: 30607324
    [No Abstract]   [Full Text] [Related]  

  • 4. A Novel
    Ndungo E; Randall A; Hazen TH; Kania DA; Trappl-Kimmons K; Liang X; Barry EM; Kotloff KL; Chakraborty S; Mani S; Rasko DA; Pasetti MF
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068560
    [No Abstract]   [Full Text] [Related]  

  • 5. An in silico hierarchal approach for drug candidate mining and validation of natural product inhibitors against pyrimidine biosynthesis enzyme in the antibiotic-resistant Shigella flexneri.
    Basharat Z; Khan K; Jalal K; Ahmad D; Hayat A; Alotaibi G; Al Mouslem A; Aba Alkhayl FF; Almatroudi A
    Infect Genet Evol; 2022 Mar; 98():105233. PubMed ID: 35104682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum β-lactamase (ESBL).
    Shen P; Fan J; Guo L; Li J; Li A; Zhang J; Ying C; Ji J; Xu H; Zheng B; Xiao Y
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):37. PubMed ID: 28499446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
    León Y; Zapata L; Salas-Burgos A; Oñate A
    Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella flexneri: a three-year antimicrobial resistance monitoring of isolates in a Children Hospital, Ahvaz, Iran.
    Khaghani S; Shamsizadeh A; Nikfar R; Hesami A
    Iran J Microbiol; 2014 Aug; 6(4):225-9. PubMed ID: 25802704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
    Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
    Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Novel Putative Drugs and Vaccine Candidates against Tick-Borne Pathogens: A Subtractive Proteomics Approach.
    Ali A; Ahmad S; Wadood A; Rehman AU; Zahid H; Qayash Khan M; Nawab J; Rahman ZU; Alouffi AS
    Vet Sci; 2020 Sep; 7(3):. PubMed ID: 32906620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteomic analysis of outer membrane vesicles from Shigella flexneri under different culture conditions.
    Chen Y; Liu L; Fu H; Wei C; Jin Q
    Biochem Biophys Res Commun; 2014 Oct; 453(4):696-702. PubMed ID: 25445584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtractive Genomics Approach for Identification of Novel Therapeutic Drug Targets in
    Fatoba AJ; Okpeku M; Adeleke MA
    Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451385
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.
    Coster TS; Hoge CW; VanDeVerg LL; Hartman AB; Oaks EV; Venkatesan MM; Cohen D; Robin G; Fontaine-Thompson A; Sansonetti PJ; Hale TL
    Infect Immun; 1999 Jul; 67(7):3437-43. PubMed ID: 10377124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential drug targets by subtractive genome analysis of Bacillus anthracis A0248: An in silico approach.
    Rahman A; Noore S; Hasan A; Ullah R; Rahman H; Hossain A; Ali Y; Islam S
    Comput Biol Chem; 2014 Oct; 52():66-72. PubMed ID: 25254941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prioritization of potential drug targets and antigenic vaccine candidates against
    Chakkyarath V; Shanmugam A; Natarajan J
    J Proteins Proteom; 2021; 12(3):201-211. PubMed ID: 34305354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.